Research Insight
UK Medical Research Council scientists create world’s first synthetic enzymes
Scientists at the UK's Medical Research Council (MRC) have created the world's first enzymes made from artificial genetic material, which are capable...
Industry Reports
Pfizer acquires Baxter’s marketed vaccines portfolio for $635m
US-based drug maker Pfizer has completed the acquisition of marketed vaccines portfolio from Baxter International for $635m. As part of the...
News
Daiichi and UCB Biopharma partner to introduce epilepsy treatment Lacosamide in Japan
Japan-based Daiichi Sankyo has signed an agreement with UCB Biopharma to jointly commercialise Lacosamide for the treatment of patients with epilepsy in Japan. ...
Research Insight
New technology may detect nucleic acid biomarkers of cancer
A new technique has been developed utilizing nanotechnology to detect disease biomarkers in the form of nucleic acids.The proof-of-concept study came from a team...
News
AstraZeneca and Cancer Research UK collaborate for new cancer medicines screening
British-Swedish drugmaker AstraZeneca has signed a memorandum of understanding (MoU) to provide drug discovery facilities for Cancer Research UK at its new...
Press Releases
Daiichi and UCB Biopharma partner to introduce epilepsy treatment Lacosamide in Japan
Japan-based Daiichi Sankyo has signed an agreement with UCB Biopharma to jointly commercialise Lacosamide for the treatment of patients with epilepsy in...
Industry Reports
Johnson & Johnson completes acquisition of AliosBioPharma for $1.75bn
US-based Johnson & Johnson (J&J) has completed the acquisition of a privately held clinical stage biopharmaceutical company, AliosBioPharma, for $1.75bn in cash. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read